Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - CAPRICOR THERAPEUTICS, INC. | v433695_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - CAPRICOR THERAPEUTICS, INC. | v433695_ex31-2.htm |
| EX-21.1 - EXHIBIT 21.1 - CAPRICOR THERAPEUTICS, INC. | v433695_ex21-1.htm |
| EX-32.2 - EXHIBIT 32.2 - CAPRICOR THERAPEUTICS, INC. | v433695_ex32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CAPRICOR THERAPEUTICS, INC. | v433695_ex31-1.htm |
| EX-10.59 - EXHIBIT 10.59 - CAPRICOR THERAPEUTICS, INC. | v433695_ex10-59.htm |
| 10-K - FORM 10-K - CAPRICOR THERAPEUTICS, INC. | v433695_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Capricor Therapeutics, Inc.
Los Angeles, California
We consent to the incorporation by reference in the Registration Statements of Capricor Therapeutics, Inc. on Form S-8 (File Nos. 333-152283, 333-175727, and 333-194317) and Form S-3 (File Nos. 333- 207149, 333-195385, and 333-202589) of our report dated March 28, 2016, relating to the consolidated financial statements, appearing in this Annual Report on Form 10-K.
| /s/ Rose, Snyder & Jacobs LLP | |
| Rose, Snyder & Jacobs LLP | |
| Encino, California | |
| March 28, 2016 |